Nicole Germino – Truist Securities

Truist Securities

A Truist Securities analyst with 9 tracked ratings across 7 distinct tickers has a 45.5% success rate on the captured sample, with a focus on 4 ratings in one category and 5 in another.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

1 years ago

2025-05-14 00:00:00+00

Track record

Aggregated

45% success rate

Bullish: 0
Hold: 1
Bearish: 0

Aggregated

Not available

Bullish: 4
Hold: 1
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
CATX	2025-05-14	buy	$8.00	Aggregated
YMABY-MABS THERAPEUTICS INC	2025-05-14	unknown	$14.00	Aggregated
CATX	2025-04-07	buy	$10.00	Aggregated
INSMINSMED INC	2025-02-21	unknown	$108.00	Aggregated
SGMO	2025-01-23	buy	$5.00	Aggregated
SGMOSANGAMO THERAPEUTICS INC	2025-01-23	unknown	$5.00	Aggregated
ASMB	2022-10-24	hold	$2.00	Aggregated
ASMBASSEMBLY BIOSCIENCES INC	2022-10-24	hold	$2.00	Aggregated
ASMB	2022-04-01	buy	$12.00	Aggregated

Tickers covered(7)

Ticker	Ratings	Last rating	Sources
CATX	2	2025-05-14	Aggregated
YMABY-MABS THERAPEUTICS INC	1	2025-05-14	Aggregated
INSMINSMED INC	1	2025-02-21	Aggregated
SGMO	1	2025-01-23	Aggregated
SGMOSANGAMO THERAPEUTICS INC	1	2025-01-23	Aggregated
ASMB	2	2022-10-24	Aggregated
ASMBASSEMBLY BIOSCIENCES INC	1	2022-10-24	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.